Winfield Associates’s PDL BioPharma, Inc. PDLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-300
| Closed | -$1K | – | 802 |
|
|
2017
Q4 | $1K | Hold |
300
| – | – | ﹤0.01% | 825 |
|
|
2017
Q3 | $1K | Hold |
300
| – | – | ﹤0.01% | 774 |
|
|
2017
Q2 | $1K | Hold |
300
| – | – | ﹤0.01% | 856 |
|
|
2017
Q1 | $1K | Hold |
300
| – | – | ﹤0.01% | 738 |
|
|
2016
Q4 | $1K | Hold |
300
| – | – | ﹤0.01% | 714 |
|
|
2016
Q3 | $1K | Hold |
300
| – | – | ﹤0.01% | 676 |
|
|
2016
Q2 | $1K | Hold |
300
| – | – | ﹤0.01% | 690 |
|
|
2016
Q1 | $1K | Hold |
300
| – | – | ﹤0.01% | 676 |
|
|
2015
Q4 | $1K | Hold |
300
| – | – | ﹤0.01% | 301 |
|
|
2015
Q3 | $2K | Hold |
300
| – | – | ﹤0.01% | 294 |
|
|
2015
Q2 | $2K | Hold |
300
| – | – | ﹤0.01% | 278 |
|
|
2015
Q1 | $2K | Hold |
300
| – | – | ﹤0.01% | 283 |
|
|
2014
Q4 | $2K | Hold |
300
| – | – | ﹤0.01% | 291 |
|
|
2014
Q3 | $2K | Sell |
300
-200
| -40% | -$1.33K | ﹤0.01% | 277 |
|
|
2014
Q2 | $4K | Hold |
500
| – | – | ﹤0.01% | 286 |
|
|
2014
Q1 | $4K | Hold |
500
| – | – | ﹤0.01% | 274 |
|
|
2013
Q4 | $4K | Buy |
+500
| New | +$4K | ﹤0.01% | 264 |
|